Evaluating on-target efficacy and off-target toxicity with Antibody Drug Conjugates (ADCs) on diseased and normal hematopoietic cells
Aisha Mergaert, Director Cell Biology Services
Connect with Discovery at Booth #64 during the World ADC San Diego meeting November 3-6, 2025.
About the Event:
Returning as the annual touchpoint for the global community, the 16th World ADC San Diego is the week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering the industry to develop differentiated ADCs that show clear advantages against standard-of-care therapies with clinically meaningful patient benefit.
